150 related articles for article (PubMed ID: 23064567)
41. Investigation of hypercalcemia.
Endres DB
Clin Biochem; 2012 Aug; 45(12):954-63. PubMed ID: 22569596
[TBL] [Abstract][Full Text] [Related]
42. MRI findings of muscle involvement in idiopathic hypereosinophilic syndrome.
Hundt W; Stäbler A; Reiser M
Eur Radiol; 1999; 9(3):525-8. PubMed ID: 10087128
[TBL] [Abstract][Full Text] [Related]
43. Vitamin D-mediated hypercalcemia in multicentric Castleman's disease.
Tanaka KI; Kanazawa I; Miyake H; Yano S; Amano C; Ishikawa N; Maruyama R; Sugimoto T
J Bone Miner Metab; 2017 Jan; 35(1):122-125. PubMed ID: 26597827
[TBL] [Abstract][Full Text] [Related]
44. Idiopathic Hypereosinophilic Syndrome With Cutaneous Manifestations and Flame Figures: A Spectrum of Eosinophilic Dermatoses Whose Features Overlap With Wells' Syndrome.
Smith SM; Kiracofe EA; Clark LN; Gru AA
Am J Dermatopathol; 2015 Dec; 37(12):910-4. PubMed ID: 25839890
[TBL] [Abstract][Full Text] [Related]
45. [Idiopathic hypereosinophilic syndrome diagnosed by symptoms of endocarditis and myocarditis].
Miyake Y; Shinomiya K; Mizukawa M; Ohara M; Takeuchi H; Oshita A; Fujita N; Kiyomoto H; Ohmori K; Kohno M
Nihon Naika Gakkai Zasshi; 2006 Oct; 95(10):2093-5. PubMed ID: 17100270
[No Abstract] [Full Text] [Related]
46. Dual SPECT imaging of Löffler's endomyocarditis in the acute phase.
Yamaguchi T; Yasumura Y; Nakatani S; Nagaya N; Ishibashi-Ueda H; Inubushi M; Ishida Y; Yamagishi M
Circulation; 2000 Oct; 102(16):2019-20. PubMed ID: 11034954
[No Abstract] [Full Text] [Related]
47. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
[TBL] [Abstract][Full Text] [Related]
48. Extreme hypercalcemia in a kidney transplant recipient.
Demir E; Karaoglan C; Yegen G; Sair B; Yazici H; Turkmen A; Sever MS
CEN Case Rep; 2018 Nov; 7(2):229-233. PubMed ID: 29705974
[TBL] [Abstract][Full Text] [Related]
49. WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia.
Cilloni D; Messa F; Martinelli G; Gottardi E; Arruga F; Defilippi I; Carturan S; Messa E; Fava M; Giugliano E; Rosso V; Catalano R; Merante S; Nicoli P; Rondoni M; Ottaviani E; Soverini S; Tiribelli M; Pane F; Baccarani M; Saglio G
Leukemia; 2007 Jul; 21(7):1442-50. PubMed ID: 17508006
[TBL] [Abstract][Full Text] [Related]
50. Hypercalcemia in metastatic GIST caused by systemic elevated calcitriol: a case report and review of the literature.
Hygum K; Wulff CN; Harsløf T; Boysen AK; Rossen PB; Langdahl BL; Safwat AA
BMC Cancer; 2015 Oct; 15():788. PubMed ID: 26499069
[TBL] [Abstract][Full Text] [Related]
51. Biochemical parameters after cholecalciferol repletion in hemodialysis: results From the VitaDial randomized trial.
Massart A; Debelle FD; Racapé J; Gervy C; Husson C; Dhaene M; Wissing KM; Nortier JL
Am J Kidney Dis; 2014 Nov; 64(5):696-705. PubMed ID: 24856872
[TBL] [Abstract][Full Text] [Related]
52. Budd-Chiari syndrome associated with hypereosinophilic syndrome; a case report.
Inoue A; Michitaka K; Shigematsu S; Konishi I; Hirooka M; Hiasa Y; Matsui H; Matsuura B; Horiike N; Hato T; Miyaoka H; Onji M
Intern Med; 2007; 46(14):1095-100. PubMed ID: 17634706
[TBL] [Abstract][Full Text] [Related]
53. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
54. A rare case of hypereosinophilic syndrome presenting with unilateral proptosis and torticollis.
Das JK; Gupta K; Deshmukh S; Shrivastava R
Indian J Ophthalmol; 2018 Oct; 66(10):1508-1511. PubMed ID: 30249857
[TBL] [Abstract][Full Text] [Related]
55. Symptomatic hypercalcemia in the first months of life: calcium-regulating hormones and treatment.
Ghirri P; Bottone U; Coccoli L; Bernardini M; Vuerich M; Cuttano A; Riparbelli C; Pellegrinetti G; Boldrini A
J Endocrinol Invest; 1999 May; 22(5):349-53. PubMed ID: 10401708
[TBL] [Abstract][Full Text] [Related]
56. Eosinophilic myeloid neoplasms.
Noel P; Mesa RA
Curr Opin Hematol; 2013 Mar; 20(2):157-62. PubMed ID: 23385615
[TBL] [Abstract][Full Text] [Related]
57. [Multiple cerebral infarctions in a patient with hypereosinophilic syndrome with Löffler endocarditis: a case report].
Ishii J; Yamamoto S; Yoshimura H; Todo K; Kawamoto M; Kohara N
Rinsho Shinkeigaku; 2015; 55(3):165-70. PubMed ID: 25786753
[TBL] [Abstract][Full Text] [Related]
58. Eosinophilic myocarditis in hypereosinophilic syndrome.
Roehrl MH; Alexander MP; Hammond SB; Ruzinova M; Wang JY; O'Hara CJ
Am J Hematol; 2011 Jul; 86(7):607-8. PubMed ID: 21681785
[No Abstract] [Full Text] [Related]
59. [Hypereosinophilic syndrome associated with antineutrophil cytoplasmic antibody].
Yoshimura N; Nishimori F; Yamazaki K; Jin Y; Beppu H; Nodera H; Matsubara O
Nihon Kokyuki Gakkai Zasshi; 1999 Jul; 37(7):554-9. PubMed ID: 10481462
[TBL] [Abstract][Full Text] [Related]
60. Unexplained hypereosinophilia and the need for cytogenetic and molecular genetic analyses.
Smith KJ; Jacobson E; Hamza S; Skelton H
Arch Dermatol; 2004 May; 140(5):584-8. PubMed ID: 15148104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
